Inflammatory Myofibroblastic Tumor of the Hilar Bile Duct: A Case Report and Literature Review

被引:1
作者
Gao, Sheng-qiang [1 ]
Bao, Yong-jin [1 ]
Luo, Jian-sheng [1 ]
机构
[1] Zhejiang Univ, Affiliated Jinhua Hosp, Dept Hepatobiliary & Pancreat Surg, Sch Med, Jinhua, Peoples R China
来源
FRONTIERS IN SURGERY | 2022年 / 9卷
关键词
inflammatory; myofibroblastic; tumor; hilar bile duct; case report; ALK; PSEUDOTUMOR; CRIZOTINIB; GENE;
D O I
10.3389/fsurg.2022.928669
中图分类号
R61 [外科手术学];
学科分类号
摘要
BackgroundInflammatory myofibroblastic tumor (IMT) is a very rare tumor and occurs seldom in the biliary tract. IMT can occur in any part of the body and in people of any age; however, it most commonly occurs in children or adolescents. Its etiology and pathogenesis are currently unknown. The clinical manifestations of a hilar inflammatory myofibroblastic tumor are atypical, and the imaging examination is nonspecific. The diagnosis is mainly based on histopathology and immunohistochemistry findings, and surgical resection is the preferred treatment method.Case DescriptionHerein, we report a rare case of hilar bile duct IMT and review the related literature. Our patient was a 54-year-old woman presenting with a 1-day history of upper abdominal pain as the main clinical symptom. She was misdiagnosed as having cholangiocarcinoma before the surgery. She underwent surgery and was ultimately diagnosed with IMT based on histopathology and immunohistochemistry findings. On 1-year follow-up, no tumor recurrence or related complications were noted.ConclusionsWe hope this case report helps clinicians gain a deeper understanding of biliary IMT of the hilum.
引用
收藏
页数:9
相关论文
共 32 条
  • [1] Aguirre-Garcia Jesus, 2004, Ann Hepatol, V3, P34
  • [2] Molecular Characterization of Inflammatory Myofibroblastic Tumors With Frequent ALK and ROS1 Gene Fusions and Rare Novel RET Rearrangement
    Antonescu, Cristina R.
    Suurmeijer, Albert J. H.
    Zhang, Lei
    Sung, Yun-Shao
    Jungbluth, Achim A.
    Travis, William D.
    Al-Ahmadie, Hikmat
    Fletcher, Christopher D. M.
    Alaggio, Rita
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2015, 39 (07) : 957 - 967
  • [3] BAHADORI M, 1973, CANCER, V31, P191, DOI 10.1002/1097-0142(197301)31:1<191::AID-CNCR2820310127>3.0.CO
  • [4] 2-D
  • [5] Combined liver transplant and pancreaticoduodenectomy for inflammatory hilar myofibroblastic tumor: Case report and review of the literature
    Berumen, Jennifer
    McCarty, Patrick
    Mo, Jun
    Newton, Kimberly
    Fairbanks, Timothy
    Mekeel, Kristin
    Hemming, Alan
    [J]. PEDIATRIC TRANSPLANTATION, 2017, 21 (02)
  • [6] Biniraj K R, 2014, J Indian Soc Periodontol, V18, P375, DOI 10.4103/0972-124X.134582
  • [7] A Comparative Study of Inflammatory Myofibroblastic Tumors and Tumefactive IgG4-related Inflammatory Lesions: the Relevance of IgG4 Plasma Cells
    Chougule, Abhijit
    Bal, Amanjit
    Das, Ashim
    Agarwal, Ritesh
    Singh, Navneet
    Rao, Katragadda L. N.
    [J]. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2016, 24 (10) : 721 - 728
  • [8] Inflammatory myofibroblastic tumor - Comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases
    Coffin, Cheryl M.
    Hornick, Jason L.
    Fletcher, Christopher D. M.
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2007, 31 (04) : 509 - 520
  • [9] Role of anaplastic lymphoma kinase inhibition in the treatment of non-small-cell lung cancer
    Croegaert, Katie
    Kolesar, Jill M.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2015, 72 (17) : 1456 - 1462
  • [10] Inflammatory pseudotumor
    Das Narla, L
    Newman, B
    Spottswood, SS
    Narla, S
    Kolli, R
    [J]. RADIOGRAPHICS, 2003, 23 (03) : 719 - 729